Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its...

FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF TWO CLINICAL TRIALS STUDYING ITS...

Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke...

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

MIND CURE ANNOUNCES CLOSING OF LNG ENERGY’S SUBSCRIPTION RECEIPT FINANCING

Navigating Psychedelics: Jewish-Informed Perspectives on Psychedelics

PT429 – From Mycophobia to Fungi Fever: The Psychedelic Space’s Growing...

Natural Medicine Advisory Bulletin #2: July 2023

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights  

Across the Threshold: A Fireside on NDE’s with Psychedelics Today

Load more